Ginkgo Bioworks (NYSE:DNA) Trading Up 7.9% - What's Next?

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report)'s stock price traded up 7.9% during trading on Wednesday . The stock traded as high as $15.44 and last traded at $15.42. 478,811 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 1,319,620 shares. The stock had previously closed at $14.29.

Ginkgo Bioworks Trading Down 8.4 %

The firm has a market cap of $711.89 million, a price-to-earnings ratio of -0.95 and a beta of 1.16. The business's fifty day moving average is $11.08.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. SBI Securities Co. Ltd. bought a new position in shares of Ginkgo Bioworks in the 4th quarter worth $29,000. KBC Group NV bought a new position in shares of Ginkgo Bioworks in the 4th quarter worth about $31,000. KLP Kapitalforvaltning AS bought a new position in shares of Ginkgo Bioworks in the 4th quarter worth about $46,000. Palumbo Wealth Management LLC bought a new stake in Ginkgo Bioworks during the 4th quarter valued at about $144,000. Finally, Y Intercept Hong Kong Ltd purchased a new stake in shares of Ginkgo Bioworks during the 4th quarter valued at about $154,000. 78.63% of the stock is currently owned by hedge funds and other institutional investors.

About Ginkgo Bioworks

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.